Recent Updates
Recently added Catalysts
HYPR Neutral Sentiment

Hyperfine, Inc. to Participate in Upcoming 2026 Jefferies Global Healthcare Conference

Key Takeaway: Hyperfine, Inc. is set to participate in the 2026 Jefferies Global Healthcare Conference. The event will provide a platform for the company to showcase its innovations and engage with industry stakeholders. Details about the specific topics to be discussed or presented at the conference have not been disclosed.
Price reaction · baseline $1.71 (2026-05-05 close) · hit after-hours · clean, no other HYPR news in the window
day 0 close · peak
+1.2%

Conference Participation Details

Jefferies Global Healthcare Conference
Date: November 18, 2025
Time: 11:30 a.m. GMT / 6:30 a.m. ET
Location: London
Format: Fireside Chat

How to Access

Investors and the general public can listen to both sessions live at:

https://investor.viatris.com

Archived versions will be available following the live events for a limited time.

Market Sentiment Analysis

Full Press Release Details

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc.(Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced plans to present at the upcoming 2026 Jefferies Global Healthcare Conference on Thursday, June 4that 8:45 am Eastern Time (ET).
A live audio webcast and an archive of the recording will be available through the Investors page of Hyperfine, Inc.’s corporate website athttps://investors.hyperfine.io.
Management will also be hosting in-person meetings. To schedule a one-on-one meeting with management, please reach out to your Jefferies representative, or the investor contact below.
About the Swoop® Portable MRI SystemsThe Swoop® Portable MR Imaging® Systems are U.S. Food and Drug Administration (FDA) cleared for brain imaging of patients of all ages. They are portable, ultra-low-field magnetic resonance imaging devices for producing images that display the internal structure of the head where full diagnostic examination is not clinically practical. When interpreted by a trained physician, these images provide information that can be useful in determining a diagnosis.
About Hyperfine, Inc.Hyperfine, Inc. (Nasdaq: HYPR) is the groundbreaking health technology company that has redefined brain imaging with the Swoop® system—the first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system capable of providing imaging at multiple points of professional care. The mission of Hyperfine, Inc. is to revolutionize patient care globally through transformational, accessible, clinically relevant diagnostic imaging. Founded by Dr. Jonathan Rothberg in a technology-based incubator called 4Catalyzer, Hyperfine, Inc. scientists, engineers, and physicists developed the Swoop® system out of a passion for redefining brain imaging methodology and how clinicians can apply accessible diagnostic imaging to patient care. For more information, visitHyperfineMRI.com.
The Hyperfine logo, Swoop, and Portable MR Imaging are registered trademarks of Hyperfine, Inc. The Swoop logo, Optive AI logo, and Optive AI are trademarks of Hyperfine, Inc.
Last updated: May 6, 2026